ALKEM LABS LTD FDA Approval ANDA 214242

ANDA 214242

ALKEM LABS LTD

FDA Drug Application

Application #214242

Application Sponsors

ANDA 214242ALKEM LABS LTD

Marketing Status

Prescription001

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL375MG0MESALAMINEMESALAMINE

FDA Submissions

UNKNOWN; ORIG1AP2021-07-15STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

ALKEM LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214242
            [companyName] => ALKEM LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"MESALAMINE","activeIngredients":"MESALAMINE","strength":"375MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/15\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-07-15
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.